F
F Nilsson
Researcher at Umeå University
Publications - 17
Citations - 1185
F Nilsson is an academic researcher from Umeå University. The author has contributed to research in topics: Smoking cessation & Cerebral blood flow. The author has an hindex of 13, co-authored 17 publications receiving 1122 citations. Previous affiliations of F Nilsson include Malmö University & Lund University.
Papers
More filters
Journal ArticleDOI
Outcome, timing and adverse events in therapeutic hypothermia after out-of-hospital cardiac arrest
Niklas Nielsen,Jan Hovdenes,F Nilsson,Sten Rubertsson,Pascal Stammet,K. Sunde,Felix Valsson,M. Wanscher,Hans Friberg +8 more
TL;DR: The Hypothermia Registry was founded to the monitor outcome, performance and complications of TH, and is recommended in guidelines.
Journal ArticleDOI
Gender differences in quit rates following smoking cessation with combination nicotine therapy: influence of baseline smoking behavior.
TL;DR: Women appear to have higher behavioral, and lower nicotine, dependence than men according to the GN-SBQ and the FTND; thus both nicotine and behavioral treatment should be tailored to women to increase their chances of abstinence.
Journal ArticleDOI
Efficacy of a nicotine inhaler in smoking cessation: a double‐blind, placebo‐controlled trial
Nina G. Schneider,Richard G. Olmstead,F Nilsson,Freny Vaghaiwalla Mody,Mikael Franzon,Kim Doan +5 more
TL;DR: The inhaler is clearly useful for short-term smoking cessation with potential for long-term efficacy and extended access to the inhaler and relapse prevention training could improve success rates.
Journal ArticleDOI
A randomized, double‐blind, placebo‐controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation
TL;DR: The nicotine sublingual tablet increased the smoking cessation rate compared to placebo, reduced craving in highly dependent smokers and was well tolerated.
Journal ArticleDOI
A comparison of a nicotine sublingual tablet and placebo for smoking cessation.
Elbert D. Glover,Penny N. Glover,Mikael Franzon,C. Rollynn Sullivan,Connie C. Cerullo,Robert M. Howell,Gordon G. Keyes,F Nilsson,Gerald R. Hobbs +8 more
TL;DR: The nicotine 2-mg sublingual tablet was effective as a smoking cessation aid and adverse events were mild and transient and reflected those reported with existing nicotine replacement formulations.